| Literature DB >> 36263308 |
Nancy J Devlin1, Elisabeth Sophia Hartgers-Gubbels2, Michael Chambers3.
Abstract
How do we measure quality of life and utility of interventions? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Nancy Devlin about incorporating quality of life in value assessment. Prof. Devlin is professor of health economics at the University of Melbourne. Her past roles include Director of Research at the Office of Health Economics (OHE) London, Professor of Health Economics at City University of London, and she has been director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She is the Chair of the Board of the EuroQol Research Foundation, the international research organization which has developed and maintains the EQ-5D patient-reported outcome (PRO) instrument. Prof Devlin explains the value of the patient voice and how it can be measured and taken into account when considering the value of healthcare interventions.Entities:
Keywords: HTA; health economics and outcomes research; health technology assessment; healthcare reimbursement; market access; payer; value demonstration
Year: 2022 PMID: 36263308 PMCID: PMC9574672 DOI: 10.2147/IJGM.S390090
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074